Heather Jones

1.2k total citations
54 papers, 808 citations indexed

About

Heather Jones is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Heather Jones has authored 54 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 27 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Heather Jones's work include Rheumatoid Arthritis Research and Therapies (33 papers), Spondyloarthritis Studies and Treatments (22 papers) and Biosimilars and Bioanalytical Methods (13 papers). Heather Jones is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (33 papers), Spondyloarthritis Studies and Treatments (22 papers) and Biosimilars and Bioanalytical Methods (13 papers). Heather Jones collaborates with scholars based in United States, United Kingdom and Canada. Heather Jones's co-authors include Lisa Marshall, Annette Szumski, Maxime Dougados, Jack F. Bukowski, Walter P. Maksymowych, Ron Pedersen, Bonnie Vlahos, I. Logeart, R. Lambert and Xenofon Baraliakos and has published in prestigious journals such as Journal of Medicinal Chemistry, Annals of the Rheumatic Diseases and Clinical Microbiology and Infection.

In The Last Decade

Heather Jones

50 papers receiving 785 citations

Peers

Countries citing papers authored by Heather Jones

Since Specialization

Citations

This map shows the geographic impact of Heather Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Jones more than expected).

Fields of papers citing papers by Heather Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Jones. The network helps show where Heather Jones may publish in the future.

Co-authorship network of co-authors of Heather Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Jones. A scholar is included among the top collaborators of Heather Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Jones. Heather Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Validation and Outcome Measures From Bend Ease: A Novel, Sensor-Based Digital Measurement Tool for Assessing At-Home Morning Stiffness and Spinal Range of Motion in Axial Spondyloarthritis 2025 ·Rheumatology and Therapy ·(unknown), Lori Siegel, Rebecca Grainger, Dan E. Webster, Tiancheng He, Liuqing Yang, (unknown), (unknown), Michelle Crouthamel, Heather Jones, Phillip J. Mease, Jeffrey R. Curtis	0
2	Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort) 2024 ·The Journal of Rheumatology ·Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge, R. Lambert, Robert Landewé, Anna Moltó, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Maxime Dougados	0
3	Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study 2020 ·Health and Quality of Life Outcomes ·Maxime Dougados, Désirée van der Heijde, Wen‐Chan Tsai, (unknown), Lisa Marshall, Heather Jones, Ron Pedersen, Bonnie Vlahos, M. Tarallo	8
4	The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis 2019 ·Arthritis Research & Therapy ·Yoshiya Tanaka, Josef S Smolen, Heather Jones, Annette Szumski, Lisa Marshall, Paul Emery	21
5	Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis 2019 ·Pediatric Rheumatology ·Majed Khraishi, (unknown), John Woolcott, Heather Jones, Lisa Marshall, Nicolino Ruperto	4
6	Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents 2019 ·BioDrugs ·Vibeke Strand, João Gonçalves, Timothy P. Hickling, Heather Jones, Lisa Marshall, John D. Isaacs	40
7	Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis 2019 ·The Journal of Rheumatology ·Paul Emery, Bonnie Vlahos, Piotr Szczypa, (unknown), Heather Jones, John Woolcott, (unknown), Catherine Rolland, Allan Gibofsky, Gustavo Citera, Sargunan Sockalingam, Lisa Marshall	19
8	Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·Maxime Dougados, Walter P. Maksymowych, Robert Landewé, Anna Moltó, Pascal Claudepierre, Manouk de Hooge, R. Lambert, R. Bonin, Jack F. Bukowski, Heather Jones, I. Logeart, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Désirée van der Heijde	33
9	Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq 2018 ·Open Access Rheumatology Research and Reviews ·(unknown), Faiq I. Gorial, (unknown), (unknown), (unknown), Mohamed Mounir, (unknown), Heather Jones, (unknown)	5
10	The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study 2018 ·Rheumatology and Therapy ·(unknown), N. Hajjaj‐Hassouni, Constance Hammond, Heather Jones, (unknown), Ron Pedersen, Bonnie Vlahos	5
11	Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis 2018 ·Rheumatology and Therapy ·(unknown), (unknown), Bonnie Vlahos, Heather Jones, Ron Pedersen, (unknown)	1
12	Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review 2018 ·BioDrugs ·Robert J. Moots, (unknown), Danielle Petersel, Catherine Rolland, Heather Jones, Eduardo Mysler	28
13	The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA 2018 ·PubMed ·Jessica A. Walsh, Heather Jones, Lotus Mallbris, Kristina Callis Duffin, Gerald G. Krueger, Daniel O. Clegg, Annette Szumski	24
14	Etanercept (Enbrel<sup>®</sup>) alternative storage at ambient temperature 2017 ·Clinical Pharmacology Advances and Applications ·(unknown), (unknown), Heather Jones, (unknown), (unknown)	6
15	MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation 2017 ·Arthritis Research & Therapy ·Walter P. Maksymowych, Stephanie Wichuk, Maxime Dougados, Heather Jones, Annette Szumski, Jack F. Bukowski, Lisa Marshall, R. Lambert	40
16	Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis 2017 ·Annals of the Rheumatic Diseases ·Walter P. Maksymowych, Stephanie Wichuk, Maxime Dougados, Heather Jones, Ron Pedersen, Annette Szumski, Lisa Marshall, Jack F. Bukowski, R. Lambert	36
17	Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review 2017 ·Rheumatology International ·Chak Sing Lau, Allan Gibofsky, Nemanja Damjanov, Sadiq Lula, Lisa Marshall, Heather Jones, Paul Emery	17
18	Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study 2015 ·Annals of the Rheumatic Diseases ·Walter P. Maksymowych, Maxime Dougados, Désirée van der Heijde, Joachim Sieper, Jürgen Braun, Gustavo Citera, Filip Van den Bosch, I. Logeart, Joseph Wajdula, Heather Jones, Lisa Marshall, R. Bonin, Ron Pedersen, Bonnie Vlahos, Sameer Kotak, Jack F. Bukowski	80
19	Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials 2015 ·The Journal of Rheumatology ·Xenofon Baraliakos, Andrew Koenig, Heather Jones, Annette Szumski, David H. Collier, Eustratios Bananis	35
20	Impact of etanercept-methotrexate therapy on patient-reported outcomes in moderately active rheumatoid arthritis: Australian results from the induction period of preserve trial 2012 ·Internal Medicine Journal ·Peter Nash, (unknown), Paul Bird, Eustratios Bananis, (unknown), Annette Szumski, Heather Jones, (unknown), (unknown), Krishan Thirunavukkarasu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact